Ocugen

Ocugen, Inc. Welcomes Dr. Huma Qamar as New Chief Medical Officer to Spearhead Clinical Developments

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies, recently announced the appointment of Dr. Huma Qamar as its Chief Medical …

Ocugen, Inc. Welcomes Dr. Huma Qamar as New Chief Medical Officer to Spearhead Clinical Developments Read More